Last edition
News about Global Pharma
Xspray Pharma Licenses Dasatinib Patents to Handa Therapeutics for US and Asian Markets
Xspray Pharma has entered into a license agreement with Handa Therapeutics, granting Handa a non-exclusive license to certain Xspray patents.
Global Pharma | 14/08/2025 | By Dineshwori | 292
PharmaTher Receives FDA Approval for KETARx Ketamine in Surgical Pain Management
PharmaTher Holdings Ltd. has received approval from the US Food and Drug Administration (FDA) for its ketamine product, KETARx, for use in surgical pain management.
Global Pharma | 14/08/2025 | By Dineshwori | 322
Centrient Pharmaceuticals Joins UN Global Compact, Strengthens Sustainability Commitment
Centrient Pharmaceuticals has officially joined the United Nations Global Compact (UNGC), reinforcing its commitment to ethical and sustainable growth.
Global Pharma | 13/08/2025 | By Dineshwori | 362
Cohance Lifesciences Invests INR 23 Cr on New cGMP Oligonucleotide Facility at Hyderabad
Cohance Lifesciences has announced an investment of INR 230 million and significant progress on its new cGMP oligonucleotide building block manufacturing facility in Hyderabad, India.
Global Pharma | 13/08/2025 | By Dineshwori | 421
Fosun Pharma Industrial has signed a global License Agreement with Expedition Therapeutics Inc., granting the US-based biotechnology company the rights to develop, manufacture, and commercialise its investigational respiratory drug XH-S004 in all regions worldwide, excluding the Chinese Mainland, Hong Kong SAR, and Macau SAR.
Global Pharma | 13/08/2025 | By Dineshwori | 316
Sandoz Partners with Elawan Energy to Decarbonize European Operations
Sandoz has signed a 10-year virtual Power Purchase Agreement (PPA) with Elawan Energy to co-develop 150 MW of new solar projects in Valladolid, Castilla y Leon, Spain.
Global Pharma | 12/08/2025 | By Dineshwori | 246
Amphastar Secures FDA Approval for Generic Iron Sucrose Injection
The US FDA has approved Amphastar's Abbreviated New Drug Application (ANDA) for iron sucrose injection, an iron replacement product indicated for the treatment of iron deficiency anemia in patients with chronic kidney disease.
Global Pharma | 12/08/2025 | By Dineshwori | 321
Lupin launches Glucagon for Injection USP, 1 mg/Vial in US Market
Lupin has launched its Glucagon for Injection USP, 1mg/vial emergency kit in the US, a bioequivalent to Eli Lilly’s product, for treating severe hypoglycemia and aiding certain radiologic procedures.
Global Pharma | 12/08/2025 | By Mrinmoy Dey | 145
Ono Pharmaceutical has signed a definitive agreement with Seikagaku Corporation for the co-development and exclusive marketing of Gel-One for osteoarthritis treatment in Japan.
Global Pharma | 11/08/2025 | By Mrinmoy Dey | 364
Zydus Secures Final USFDA Approval for Diltiazem Hydrochloride Tablets
Zydus Lifesciences has received final USFDA approval to market Diltiazem Hydrochloride Tablets in 30 mg, 60 mg, 90 mg, and 120 mg dosages for the treatment of chronic stable angina and angina due to coronary artery spasm in the US.
Global Pharma | 11/08/2025 | By Mrinmoy Dey | 204
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy